Starsource Multitrade (506365) Q4 97/98 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 97/98 earnings summary
22 Oct, 2026Executive summary
Factory operations were suspended under a lockout effective 28 November 1997; the lockout continued through year-end. The reported loss for the year was Rs. 83,23,334 before tax.
Discussions to lease or license part of the plant and machinery to other chemical manufacturers were at an advanced stage.
Financial highlights
Net sales, inclusive of excise duty and sales tax, were Rs. 15,52,630 versus Rs. 5,21,562 in 1996-97; miscellaneous income was Rs. 47,31,662 versus Rs. 1,21,95,353.
Gross loss was Rs. 68,03,119 versus gross profit of Rs. 16,48,590; depreciation was Rs. 15,20,215, resulting in a pre-tax loss of Rs. 83,23,334.
Loss after tax was Rs. 82,93,334; after the prior-year balance, Rs. 52,42,122 was carried to the balance sheet.
Outlook and guidance
Leasing or licensing part of the existing plant and machinery was being explored, with prospective chemical manufacturers identified and negotiations advanced.
Latest events from Starsource Multitrade
- Tax write-back lifted net profit as factory operations restarted and Fine Chemicals trials advanced.506365
Q4 96/97 - Continued lockout, Rs.4.488m net loss, and major unprovided liabilities and investment impairment.506365
Q4 98/99 - Lockout and a widening Rs.4.38m loss drove plans to explore disposal or leasing.506365
Q4 04/05 - Lockout halted operations; FY2002-03 net loss was Rs.863,221 as leasing talks continued.506365
Q4 02/03 - Manufacturing ceased after asset sales; diversification and material financial risks remain.506365
Q4 06/07 - Manufacturing stayed halted; FY08 PAT fell to Rs 0.08 lakh as diversification remained uncertain.506365
Q4 07/08 - Suspended manufacturing, falling income and auditor-flagged asset and loan risks defined FY10.506365
Q4 09/10 - A modest return to profit amid suspended operations, material audit concerns, and suspended share trading.506365
Q4 10/11 - Investment-sale income drove FY12 profit as manufacturing remained suspended.506365
Q4 11/12